David A. Mrazek

9.2k total citations · 1 hit paper
145 papers, 6.3k citations indexed

About

David A. Mrazek is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, David A. Mrazek has authored 145 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 37 papers in Clinical Psychology and 20 papers in Pharmacology. Recurrent topics in David A. Mrazek's work include Child and Adolescent Psychosocial and Emotional Development (29 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Bipolar Disorder and Treatment (13 papers). David A. Mrazek is often cited by papers focused on Child and Adolescent Psychosocial and Emotional Development (29 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Bipolar Disorder and Treatment (13 papers). David A. Mrazek collaborates with scholars based in United States, Japan and Germany. David A. Mrazek's co-authors include Mary D. Klinnert, Joyce Tombran‐Tink, C. Anthony Altar, Patricia J. Mrazek, Joanna M. Biernacka, Irina Degtiar, John Hornberger, Maureen S. Drews, Stephanie Schmitz and Karen Snyder and has published in prestigious journals such as JAMA, Journal of Neuroscience and PLoS ONE.

In The Last Decade

David A. Mrazek

139 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013

2014 409 citations David A. Mrazek, John Hornberger et al. Psychiatric Services profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Mrazek United States	46	1.5k	1.5k	1.2k	805	752	145	6.3k
Toshiyuki Someya Japan	38	1.1k 0.7×	1.5k 1.0×	1.1k 1.0×	372 0.5×	439 0.6×	281	5.9k
Nancy Berman United States	47	331 0.2×	1.4k 0.9×	1.5k 1.3×	1.2k 1.5×	729 1.0×	104	7.9k
Stefan Bleich Germany	51	1.2k 0.8×	1.0k 0.7×	2.1k 1.8×	578 0.7×	1.0k 1.3×	329	7.8k
Mark Hyman Rapaport United States	51	2.1k 1.4×	3.2k 2.1×	777 0.7×	1.7k 2.1×	681 0.9×	194	10.5k
Chunbo Li China	43	1.4k 0.9×	3.7k 2.4×	550 0.5×	559 0.7×	493 0.7×	326	8.3k
Xiangyang Zhang China	49	1.7k 1.1×	2.3k 1.5×	1.1k 0.9×	591 0.7×	901 1.2×	432	8.6k
Richard Jed Wyatt United States	51	1.4k 0.9×	4.3k 2.8×	1.3k 1.1×	762 0.9×	899 1.2×	193	11.0k
Antoni Gual Spain	41	839 0.5×	420 0.3×	560 0.5×	713 0.9×	518 0.7×	268	7.1k
Yena Lee Canada	48	2.2k 1.4×	1.9k 1.2×	629 0.5×	2.2k 2.7×	727 1.0×	209	8.7k
Keith L. Davis United States	53	842 0.5×	2.4k 1.6×	1.7k 1.4×	1.5k 1.8×	1.6k 2.2×	238	9.2k

Countries citing papers authored by David A. Mrazek

Since Specialization

Citations

This map shows the geographic impact of David A. Mrazek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Mrazek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Mrazek more than expected).

Fields of papers citing papers by David A. Mrazek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Mrazek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Mrazek. The network helps show where David A. Mrazek may publish in the future.

Co-authorship network of co-authors of David A. Mrazek

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Mrazek. A scholar is included among the top collaborators of David A. Mrazek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Mrazek. David A. Mrazek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karpyak, Victor M., Joanna M. Biernacka, Jennifer R. Geske, et al.. (2016). Gender‐specific effects of comorbid depression and anxiety on the propensity to drink in negative emotional states. Addiction. 111(8). 1366–1375. 51 indexed citations

Mrazek, David A., Joanna M. Biernacka, Donald E. McAlpine, et al.. (2014). Treatment Outcomes of Depression. Journal of Clinical Psychopharmacology. 34(3). 313–317. 32 indexed citations

Mrazek, David A., John Hornberger, C. Anthony Altar, & Irina Degtiar. (2014). A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013. Psychiatric Services. 65(8). 977–987. 409 indexed citations breakdown →

Shiroma, Paulo, Maureen S. Drews, Jennifer R. Geske, & David A. Mrazek. (2013). SLC6A4 Polymorphisms and Age of Onset in Late-life Depression on Treatment Outcomes with Citalopram: A Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Report. American Journal of Geriatric Psychiatry. 22(11). 1140–1148. 15 indexed citations

Biernacka, Joanna M., Jennifer R. Geske, Terry D. Schneekloth, et al.. (2013). Replication of Genome Wide Association Studies of Alcohol Dependence: Support for Association with Variation in ADH1C. PLoS ONE. 8(3). e58798–e58798. 26 indexed citations

Ji, Yuan, Scott J. Hebbring, Yubo Chai, et al.. (2012). Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics. The Pharmacogenomics Journal. 13(5). 456–463. 52 indexed citations

Abo, Ryan, Scott J. Hebbring, Yuan Ji, et al.. (2012). Merging pharmacometabolomics with pharmacogenomics using ‘1000 Genomes’ single-nucleotide polymorphism imputation. Pharmacogenetics and Genomics. 22(4). 247–253. 43 indexed citations

Biernacka, Joanna M., Susan L. McElroy, Scott J. Crow, et al.. (2011). Pharmacogenomics of antidepressant induced mania: A review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. Journal of Affective Disorders. 136(1-2). e21–e29. 30 indexed citations

Shinozaki, Gen, Magdalena Romanowicz, Simon Kung, & David A. Mrazek. (2010). A new interaction between SLC6A4 variation and child abuse is associated with resting heart rate. Depression and Anxiety. 28(3). 227–233. 6 indexed citations

10.

Karpyak, Victor M., Jeonghyun Kim, Joanna M. Biernacka, et al.. (2009). Sequence Variations of the Human MPDZ Gene and Association With Alcoholism in Subjects With European Ancestry. Alcoholism Clinical and Experimental Research. 33(4). 712–721. 27 indexed citations

11.

Brighina, Laura, Nicole Schneider, Timothy G. Lesnick, et al.. (2009). α-Synuclein, alcohol use disorders, and Parkinson disease: A case–control study. Parkinsonism & Related Disorders. 15(6). 430–434. 29 indexed citations

12.

Karpyak, Victor M., Daniel K. Hall‐Flavin, & David A. Mrazek. (2008). Can Genetics Predict Risk for Alcohol Dependence? Inherited Variations Affect Response to Alcohol and to Alcoholism Treatments. Current psychiatry. 7(3). 57. 1 indexed citations

13.

Faulkner, Larry R., Daniel K. Winstead, Victor I. Reus, et al.. (2008). The ABPN Maintenance of Certification Program for Psychiatrists: Past History, Current Status, and Future Directions. Academic Psychiatry. 32(3). 241–248. 3 indexed citations

14.

Schmitz, Stephanie & David A. Mrazek. (2001). Genetic and Environmental Influences on the Associations Between Attention Problems and Other Problem Behaviors. Twin Research. 4(6). 453–458. 24 indexed citations

15.

Cao, Wei, Joyce Tombran‐Tink, R. Elias, et al.. (2001). In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor.. PubMed. 42(7). 1646–52. 167 indexed citations

16.

Ohno‐Matsui, Kyoko, I. Morita, Joyce Tombran‐Tink, et al.. (2001). Novel mechanism for age‐related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF. Journal of Cellular Physiology. 189(3). 323–333. 217 indexed citations

17.

Lemery‐Chalfant, Kathryn, H. Hill Goldsmith, Mary D. Klinnert, & David A. Mrazek. (1999). Developmental models of infant and childhood temperament.. Developmental Psychology. 35(1). 189–204. 126 indexed citations

18.

Mrazek, David A., Mary D. Klinnert, Patricia J. Mrazek, et al.. (1999). Prediction of early-onset asthma in genetically at-risk children. Pediatric Pulmonology. 27(2). 85–94. 77 indexed citations

19.

Klinnert, Mary D., Patricia J. Mrazek, & David A. Mrazek. (1994). Early Asthma Onset. Psychiatry. 57(1). 51–61. 52 indexed citations

20.

Mrazek, David A.. (1991). Response to the Bauserman Critique. Journal of Homosexuality. 20(1-2). 317–318. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact